Literature DB >> 28319902

Ultra-high sensitivity of the non-immunological affinity of graphene oxide-peptide-based surface plasmon resonance biosensors to detect human chorionic gonadotropin.

Nan-Fu Chiu1, Chia-Tzu Kuo2, Ting-Li Lin2, Chia-Chen Chang3, Chen-Yu Chen4.   

Abstract

Specific peptide aptamers can be used in place of expensive antibody proteins, and they are gaining increasing importance as sensing probes due to their potential in the development of non-immunological assays with high sensitivity, affinity and specificity for human chorionic gonadotropin (hCG) protein. We combined graphene oxide (GO) sheets with a specific peptide aptamer to create a novel, simple and label-free tool to detect abnormalities at an early stage of pregnancy, a GO-peptide-based surface plasmon resonance (SPR) biosensor. This is the first binding interface experiment to successfully demonstrate binding specificity in kinetic analysis biomechanics in peptide aptamers and GO sheets. In addition to the improved affinity offered by the high compatibility with the target hCG protein, the major advantage of GO-peptide-based SPR sensors was their reduced nonspecific adsorption and enhanced sensitivity. The calculation of total electric field intensity (ΔE) in the GO-based sensing interfaces was significantly enhanced by up to 1.2 times that of a conventional SPR chip. The GO-peptide-based chip (1mM) had a high affinity (KA) of 6.37×1012M-1, limit of detection of 0.065nM and ultra-high sensitivity of 16 times that of a conventional SPR chip. The sensitivity of the slope ratio of the low concentration hCG protein assay in linear regression analysis was GO-peptide (1mM): GO-peptide (0.1mM): conventional chip (8-mercaptooctanoic acid)-peptide (0.1mM)=8.6: 3.3: 1. In summary, the excellent binding affinity, low detection limit, high sensitivity, good stability and specificity suggest the potential of this GO-peptide-based SPR chip detection method in clinical application. The development of real-time whole blood analytic and diagnostic tools to detect abnormalities at an early stage of pregnancy is a promising technique for future clinical application.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Graphene oxide (GO); Human chorionic gonadotropin (hCG); Peptide aptamer; Surface plasmon resonance (SPR)

Mesh:

Substances:

Year:  2017        PMID: 28319902     DOI: 10.1016/j.bios.2017.03.008

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  12 in total

Review 1.  Biosensors for Detection of Human Placental Pathologies: A Review of Emerging Technologies and Current Trends.

Authors:  Jia Liu; Babak Mosavati; Andrew V Oleinikov; E Du
Journal:  Transl Res       Date:  2019-05-20       Impact factor: 7.012

2.  Determination of the Highly Sensitive Carboxyl-Graphene Oxide-Based Planar Optical Waveguide Localized Surface Plasmon Resonance Biosensor.

Authors:  Chien-Hsing Chen; Chang-Yue Chiang
Journal:  Nanomaterials (Basel)       Date:  2022-06-22       Impact factor: 5.719

Review 3.  Graphene-Based Materials for Biosensors: A Review.

Authors:  Phitsini Suvarnaphaet; Suejit Pechprasarn
Journal:  Sensors (Basel)       Date:  2017-09-21       Impact factor: 3.576

4.  Development of a bioaffinity SPR immunosensor based on functionalized graphene oxide for the detection of pregnancy-associated plasma protein A2 in human plasma.

Authors:  Nan-Fu Chiu; Ming-Jung Tai; Hwai-Ping Wu; Ting-Li Lin; Chen-Yu Chen
Journal:  Int J Nanomedicine       Date:  2019-08-22

5.  High-affinity carboxyl-graphene oxide-based SPR aptasensor for the detection of hCG protein in clinical serum samples.

Authors:  Nan-Fu Chiu; Chia-Tzu Kuo; Chen-Yu Chen
Journal:  Int J Nanomedicine       Date:  2019-07-03

6.  Simultaneous Real-Time Detection of Pregnancy-Associated Plasma Protein-A and -A2 Using a Graphene Oxide-Based Surface Plasmon Resonance Biosensor.

Authors:  Shi-Yuan Fan; Nan-Fu Chiu; Chie-Pein Chen; Chia-Chen Chang; Chen-Yu Chen
Journal:  Int J Nanomedicine       Date:  2020-03-26

Review 7.  A Review of Graphene-Based Surface Plasmon Resonance and Surface-Enhanced Raman Scattering Biosensors: Current Status and Future Prospects.

Authors:  Devi Taufiq Nurrohman; Nan-Fu Chiu
Journal:  Nanomaterials (Basel)       Date:  2021-01-15       Impact factor: 5.076

8.  Immunoassay-Amplified Responses Using a Functionalized MoS2-Based SPR Biosensor to Detect PAPP-A2 in Maternal Serum Samples to Screen for Fetal Down's Syndrome.

Authors:  Nan-Fu Chiu; Ming-Jung Tai; Devi Taufiq Nurrohman; Ting-Li Lin; Ying-Hao Wang; Chen-Yu Chen
Journal:  Int J Nanomedicine       Date:  2021-04-09

9.  Enhanced Plasmonic Biosensors of Hybrid Gold Nanoparticle-Graphene Oxide-Based Label-Free Immunoassay.

Authors:  Nan-Fu Chiu; Chi-Chu Chen; Cheng-Du Yang; Yu-Sheng Kao; Wei-Ren Wu
Journal:  Nanoscale Res Lett       Date:  2018-05-16       Impact factor: 4.703

10.  Clinical Application for Screening Down's Syndrome by Using Carboxylated Graphene Oxide-Based Surface Plasmon Resonance Aptasensors.

Authors:  Nan-Fu Chiu; Ying-Hao Wang; Chen-Yu Chen
Journal:  Int J Nanomedicine       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.